Gentherm Reports 2026 Third Quarter Results
Repurchased $60 Million of Common Stock in October NOVI, Michigan, October 22, 2026 -- Gentherm (NASDAQ:THRM), a global leader of innovative thermal and precision flow management technologies, today announced its financial results for the third quarter ended September 30, 2026.
“Our third quarter results were in line with expectations as we made continued progress on growth and operational excellence initiatives, while completing the Modine Performance Technologies combination on October 1,” said Bill Presley, the Company's President and CEO. “With the completion of the transaction, we are fundamentally a different company. We are entering an exciting new phase for Gentherm with industry leading platforms and I am increasingly confident in the significant value creation opportunities ahead.”
Expanded portfolio of differentiated technologies with launch of ThermAffyx™ Patient Safety System and Puls.A™.
Product revenues of $405.1 million increased 4.7% from $386.9 million in the prior year. Excluding the impact of foreign currency translation, product revenues increased 4.4%.
Automotive Climate and Comfort Solutions revenue increased 8.8% year over year, or 8.5% excluding the impact of foreign currency translation, outperforming S&P Global’s mid-October light vehicle production report in our relevant markets by 12 percentage points.
Gross margin was 23.3%, compared to 24.6% in the prior year. The decrease was primarily driven by foreign exchange, higher net material costs and inflation, partially offset by strong operating leverage.
Net (loss) income was $(2.6) million, compared to $14.9 million in the prior year.
Adjusted EBITDA was $45.0 million, or 11.1% of revenue, compared to $49.0 million, or 12.7% of revenue, in the prior year.
GAAP diluted (loss) earnings per share was $(0.08), compared to $0.49 in the prior year.
Adjusted diluted earnings per share was $0.33,compared to $0.73 in the prior year.
Cash flow from operations was $36.0 million, compared to $87.8 million in the prior year.
Adjusted free cash flow was $59.5 million, compared to $72.3 million in the prior year.
The Company provides various non-GAAP financial measures in this release. See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for investors and limitations, as well as reconciliations below to the most directly comparable GAAP financial measures. Guidance The Company updated its full year 2026 guidance to reflect the expected contribution from Modine Performance Technologies in the fourth quarter¹.
¹2026 guidance based on tariffs currently in effect as of today, our current forecast of customer demand and expectations of near-term conditions, light vehicle production in our relevant markets decreasing at a low single digit rate for full year 2026 versus 2025, and a EUR to USD exchange rate of $1.15/Euro. Capital Allocation Update • On July 1, acquired Innovative Medical Equipment, LLC, provider of the ThermaZone® thermal therapy device, expanding thermal management product portfolio and providing strong cross-selling opportunities by leveraging complementary customer bases across additional healthcare channels. • On October 1, completed combination with Modine’s Performance Technologies business. • On October 7, returned $63.5 million to shareholders through a special cash dividend of $2.07 per share as part of the Modine transaction. • In July, the Board of Directors authorized a new stock repurchase program of up to $400 million of the Company’s issued and outstanding common stock. Following the closing of the transaction with Modine in October, the Company repurchased $60 million of common stock. As of today, the program has approximately $340 million of stock repurchase authorization remaining. • Third quarter ended with net leverage of ~0.4x and liquidity of $494.2 million. “As expected, following the combination with Modine Performance Technologies, we remain in a strong financial position and continue to have confidence in the ability to generate significant cash moving forward,” said Jon Douyard, the Company’s Chief Financial Officer. “We believe the current share price does not reflect the value of the Company. We previously communicated our intention to repurchase shares following the Modine transaction. Since closing, we have repurchased $60 million and we remain committed to returning capital to shareholders, particularly in times of value dislocation.” Conference Call As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside the U.S.). The passcode for the live call is 13763267. A live webcast and one-year archived replay of the call, as well as a copy of the supplemental materials that will be used during the conference call, can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on November 5, 2026. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13763267. Investor ContactGregory [email protected]
Gentherm (NASDAQ: THRM) is a global leader of innovative thermal and precision flow management technologies. The Company brings together industry leading products from Gentherm’s climate, comfort and valves businesses serving the light vehicle, medical, and home and office markets, with Modine’s highly engineered, mission-critical thermal solutions serving commercial vehicle, off- highway equipment, light vehicle and power generation markets. Gentherm has more than 18,000 employees in facilities across 17 countries. For more information, go towww.gentherm.com.
Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, third party information and projections from sources that management believes to be reputable, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:
macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;
the impact of, and our ability to mitigate the effects of, global economic and trade policies, including increases in duties, tariffs and taxation on the import or export of our products related to U.S. trade disputes;
increasing U.S. and global competition, including with non-traditional entrants;
our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;
the evolution and challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
the constraints in the supply chain environment, and inflationary and other cost pressures;
the production levels of our major customers and OEMs in our relevant markets and sudden fluctuations in such production levels;
our business in China, which is subject to unique operational, competitive, geopolitical, regulatory and economic risks;
the impact of our global operations, including our cost structure and global manufacturing footprint, operations within Ukraine, and foreign currency and exchange risk;
our product quality and safety and impact of product safety recalls and alleged defects in products;
a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers;
our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;
our ability to execute efforts to optimize our global supply chain and manufacturing footprint, including opening new facilities and transferring production;
our ability to source, consummate, integrate and achieve planned benefits of strategic acquisitions, investments and, as applicable, exits;
any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks, including risks associated with use of artificial intelligence capabilities in our business operations;
our ability to project future sales volume based on third-party information, based on which we manage our business;
legal and regulatory proceedings and claims involving us or one of our major customers;
the effects of climate change and regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;
our borrowing availability under our revolving credit facility, as well as the ability to access the capital markets, to support our planned growth; and
Furthermore, important factors related to the combination with Modine Performance Technologies (the “Transaction”) could cause actual results to differ materially from those currently anticipated, including:
uncertainty of the expected financial performance of the combined company following completion of the Transaction;
difficulties and delays in the combined company achieving revenue and cost synergies;
changes in general economic and/or industry specific conditions or any volatility resulting from the imposition of and changing policies, including those policies with respect to tariffs; and
The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time.
Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; Adjusted net income; Adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); Quarter- to-date Operating Cash Flow; Free Cash Flow; Adjusted Free Cash Flow; Adjusted Free Cash Flow Conversion rate; net capital expenditures (“net CAPEX”); Net Debt; Liquidity; Net Leverage Ratio (“Net Leverage”); revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Adjusted operating expenses; Pro Forma Revenue; Pro Forma Adjusted EBITDA; and Pro Forma Adjusted EBITDA Margin, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock based compensation expenses, restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted net income as earnings adjusted by restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EPS as Adjusted net income divided by the Company’s weighted average shares outstanding. The Company defines Quarter-to-date Operating Cash Flow as Net cash provided by/(used in) operating activities for the current period, less that of the immediately preceding period. The Company defines Free Cash Flow as Net cash provided by/(used in) operating activities plus Proceeds from the sale of property and equipment less Purchases of property and equipment. The Company defines net CAPEX as Purchases of property and equipment less Proceeds from the sale of property and
equipment. The Company defines Adjusted Free Cash Flow as Net cash provided by/(used in) operating activities, excluding cash restructuring expenses, net and other gains and losses not reflective of the Company’s ongoing operations, less net CAPEX. The Company defines Adjusted Free Cash Flow Conversion rate as Adjusted Free Cash Flow divided by Adjusted EBITDA. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines Liquidity as the sum of cash and cash equivalents and availability under the Company’s revolving line of credit. The Company defines Net Leverage as Net Debt divided by Adjusted EBITDA for the trailing four fiscal quarters. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified. The Company defines Adjusted operating expenses as operating expenses excluding related non-cash stock based compensation, restructuring expenses, net, and other gains and losses not reflective of the Company’s ongoing operations. The Company defines Pro Forma Revenue as Gentherm’s product revenues for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Net sales for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure. The Company defines Pro Forma Adjusted EBITDA as Gentherm’s Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure and go-forward operational alignment. The Company defines Pro Forma Adjusted EBITDA Margin as Pro Forma Adjusted EBITDA divided by Pro Forma Revenue.
The Company’s reconciliations are included in this release or can be found in the supplemental materials for this reporting period on the Company’s website.
In evaluating its business, the Company considers and uses Quarter-to-date Operating Cash Flow, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Net Debt, Net Leverage and Liquidity as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income/(loss), revenue or other consolidated income/(loss) statement or cash flow statement data prepared in accordance with GAAP.
Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Adjusted EPS, Pro Forma Revenue, Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results. GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF (LOSS) INCOME (Dollars in thousands, except per share data) (Unaudited)
GENTHERM INCORPORATED REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT (Dollars in thousands) (Unaudited)
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN (Dollars in thousands) (Unaudited)
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE (Dollars in thousands, except per share data) (Unaudited)
GENTHERM INCORPORATED CONSOLIDATED CONDENSED BALANCE SHEETS (Dollars in thousands, except share data) (Unaudited)
September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── ASSETS Current Assets: Cash and cash $ 252,098 $ 160,833 equivalents Accounts receivable, 326,217 281,083 net Inventory: Raw materials 127,403 128,314 Work in process 44,437 35,429 Finished goods 91,647 88,959 Inventory, net 263,487 252,702 Other current assets 85,678 82,332 Total current assets 927,480 776,950 Property and 263,561 270,614 equipment, net Goodwill 122,258 108,918 Other intangible 63,858 52,796 assets, net Operating lease 48,674 56,524 right-of-use assets Deferred income tax 93,853 93,552 assets Other non-current 42,615 37,075 assets Total assets $ 1,562,299 $ 1,396,429 LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities: Accounts payable $ 298,183 $ 260,487 Current lease 7,846 9,646 liabilities Current maturities of 912 73 long-term debt Other current 144,999 134,104 liabilities Total current 451,940 404,310 liabilities Long-term debt, less 319,531 189,000 current maturities Non-current lease 42,469 48,105 liabilities Pension benefit 3,281 3,748 obligation Other non-current 23,760 30,943 liabilities Total liabilities $ 840,981 $ 676,106 Shareholders’ Equity: Common Stock: No par value; 110,000,000 shares authorized 30,710,902 and 30,526,231 issued and 13,442 5,611 outstanding at September 30, 2026 and December 31, 2025, respectively Paid-in capital 1,590 1,590 Accumulated other (13,848 ) (964 ) comprehensive loss Accumulated earnings 720,134 714,086 Total shareholders’ 721,318 720,323 equity Total liabilities and shareholders’ $ 1,562,299 $ 1,396,429 equity
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Dollars in thousands) (Unaudited)
Nine Months Ended Operating September 30, Activities: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 6,048 $ 15,298 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and 44,201 39,478 amortization Deferred income (9,548 ) (12,836 ) taxes Stock based 10,371 10,573 compensation Loss on disposition of property and 121 2,671 equipment Provisions for 4,086 5,234 inventory Other non-cash items, including unrealized foreign (1,018 ) 30,957 currency (gain) loss Changes in assets and liabilities: Accounts (43,474 ) (20,543 ) receivable, net Inventory (22,133 ) (20,136 ) Other assets (1,403 ) (22,325 ) Accounts payable 43,305 33,514 Other liabilities 5,451 25,935 Net cash provided by operating 36,007 87,820 activities Investing Activities: Purchases of property and (22,558 ) (33,378 ) equipment Proceeds from the sale of property 83 3,770 and equipment Acquisition of business, net of (34,152 ) — cash acquired Cost of technology (121 ) (915 ) investments Proceeds from deferred purchase price of — 744 factored receivables Net cash used in investing (56,748 ) (29,779 ) activities Financing — — Activities: Borrowings on debt 204,000 72,000 Repayments of debt (85,887 ) (103,112 ) Cash paid for (2,761 ) — financing new loans Taxes withheld and paid on employees' (2,540 ) (1,306 ) stock based compensation Cash paid for the repurchase of — (10,015 ) Common Stock Net cash provided by (used in) 112,812 (42,433 ) financing activities Foreign currency (806 ) 4,508 effect Net increase in cash and cash 91,265 20,116 equivalents Cash and cash equivalents at 160,833 134,134 beginning of period Cash and cash equivalents at end $ 252,098 $ 154,250 of period
Full text with the tables
Exhibit 99.1
Gentherm Reports 2026 Third Quarter Results
Delivered Revenue of $405 Million, up 4.4% (ex-FX) Year-over-Year
2026 Full Year Guidance Updated to Include Modine Performance Technologies
Repurchased $60 Million of Common Stock in October
NOVI, Michigan, October 22, 2026 -- Gentherm (NASDAQ:THRM), a global leader of
innovative thermal and precision flow management technologies, today announced
its financial results for the third quarter ended September 30, 2026.
“Our third quarter results were in line with expectations as we made continued
progress on growth and operational excellence initiatives, while completing the
Modine Performance Technologies combination on October 1,” said Bill Presley,
the Company's President and CEO. “With the completion of the transaction, we are
fundamentally a different company. We are entering an exciting new phase for
Gentherm with industry leading platforms and I am increasingly confident in the
significant value creation opportunities ahead.”
Third Quarter Highlights
Secured Automotive New Business Awards totaling $555 million in the quarter.
Expanded portfolio of differentiated technologies with launch of ThermAffyx™
Patient Safety System and Puls.A™.
Product revenues of $405.1 million increased 4.7% from $386.9 million in the
prior year. Excluding the impact of foreign currency translation, product
revenues increased 4.4%.
Automotive Climate and Comfort Solutions revenue increased 8.8% year over year,
or 8.5% excluding the impact of foreign currency translation, outperforming S&P
Global’s mid-October light vehicle production report in our relevant markets by
12 percentage points.
Gross margin was 23.3%, compared to 24.6% in the prior year. The decrease was
primarily driven by foreign exchange, higher net material costs and inflation,
partially offset by strong operating leverage.
Net (loss) income was $(2.6) million, compared to $14.9 million in the prior
year.
Adjusted EBITDA was $45.0 million, or 11.1% of revenue, compared to $49.0
million, or 12.7% of revenue, in the prior year.
GAAP diluted (loss) earnings per share was $(0.08), compared to $0.49 in the
prior year.
Adjusted diluted earnings per share was $0.33,compared to $0.73 in the prior
year.
Cash flow from operations was $36.0 million, compared to $87.8 million in the
prior year.
Adjusted free cash flow was $59.5 million, compared to $72.3 million in the
prior year.
The Company provides various non-GAAP financial measures in this release. See
“Use of Non-GAAP Measures” below for additional information, including
definitions, usefulness for investors and limitations, as well as
reconciliations below to the most directly comparable GAAP financial measures.
Guidance The Company updated its full year 2026 guidance to reflect the expected
contribution from Modine Performance Technologies in the fourth quarter¹.
As of July 2026 As of October 2026
Product Revenues $1.55B – $1.65B $1.825B – $1.925B
Adjusted EBITDA $185M – $200M $210M – $230M
Adjusted Free Cash Flow $85M – $100M $100M – $120M
¹2026 guidance based on tariffs currently in effect as of today, our current
forecast of customer demand and expectations of near-term conditions, light
vehicle production in our relevant markets decreasing at a low single digit rate
for full year 2026 versus 2025, and a EUR to USD exchange rate of $1.15/Euro.
Capital Allocation Update • On July 1, acquired Innovative Medical Equipment,
LLC, provider of the ThermaZone® thermal therapy device, expanding thermal
management product portfolio and providing strong cross-selling opportunities by
leveraging complementary customer bases across additional healthcare channels. •
On October 1, completed combination with Modine’s Performance Technologies
business. • On October 7, returned $63.5 million to shareholders through a
special cash dividend of $2.07 per share as part of the Modine transaction. • In
July, the Board of Directors authorized a new stock repurchase program of up to
$400 million of the Company’s issued and outstanding common stock. Following the
closing of the transaction with Modine in October, the Company repurchased $60
million of common stock. As of today, the program has approximately $340 million
of stock repurchase authorization remaining. • Third quarter ended with net
leverage of ~0.4x and liquidity of $494.2 million. “As expected, following the
combination with Modine Performance Technologies, we remain in a strong
financial position and continue to have confidence in the ability to generate
significant cash moving forward,” said Jon Douyard, the Company’s Chief
Financial Officer. “We believe the current share price does not reflect the
value of the Company. We previously communicated our intention to repurchase
shares following the Modine transaction. Since closing, we have repurchased $60
million and we remain committed to returning capital to shareholders,
particularly in times of value dislocation.” Conference Call As previously
announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time
to review these results. The dial-in number for the call is 1-877-407-4018
(callers in the U.S.) or +1-201-689-8471 (callers outside the U.S.). The
passcode for the live call is 13763267. A live webcast and one-year archived
replay of the call, as well as a copy of the supplemental materials that will be
used during the conference call, can be accessed on the Events page of the
Investor section of Gentherm's website at www.gentherm.com. A telephonic replay
will be available approximately two hours after the call until 11:59 pm Eastern
Time on November 5, 2026. The replay can be accessed by dialing 1-844-512-2921
(callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The
passcode for the replay is 13763267.
Investor ContactGregory [email protected]
Media ContactHaley [email protected]
About Gentherm
Gentherm (NASDAQ: THRM) is a global leader of innovative thermal and precision
flow management technologies. The Company brings together industry leading
products from Gentherm’s climate, comfort and valves businesses serving the
light vehicle, medical, and home and office markets, with Modine’s highly
engineered, mission-critical thermal solutions serving commercial vehicle, off-
highway equipment, light vehicle and power generation markets. Gentherm has more
than 18,000 employees in facilities across 17 countries. For more information,
go towww.gentherm.com.
Forward-Looking Statements
Except for historical information contained herein, statements in this release
are forward-looking statements that are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements represent Gentherm Incorporated's goals, beliefs,
plans and expectations about its prospects for the future and other future
events. The forward-looking statements included in this release are made as of
the date hereof or as of the date specified herein and are based on management's
reasonable expectations and beliefs. In making these statements we rely on
assumptions and analysis based on our experience and perception of historical
trends, current conditions and expected future developments, third party
information and projections from sources that management believes to be
reputable, as well as other factors we consider appropriate under the
circumstances. Such statements are subject to a number of important assumptions,
significant risks and uncertainties (some of which are beyond our control) and
other factors that may cause actual results or performance to differ materially
from that described in or indicated by the forward-looking statements, including
but not limited to:
macroeconomic, geopolitical and similar global factors in the cyclical
Automotive industry;
the impact of, and our ability to mitigate the effects of, global economic and
trade policies, including increases in duties, tariffs and taxation on the
import or export of our products related to U.S. trade disputes;
increasing U.S. and global competition, including with non-traditional entrants;
our ability to effectively manage new product launches and research and
development, and the market acceptance of such products and technologies;
the evolution and challenges of the automotive industry towards electric
vehicles, autonomous vehicles and mobility on demand services, and related
consumer behaviors and preferences;
our ability to convert automotive new business awards into product revenues;
the constraints in the supply chain environment, and inflationary and other cost
pressures;
the production levels of our major customers and OEMs in our relevant markets
and sudden fluctuations in such production levels;
our business in China, which is subject to unique operational, competitive,
geopolitical, regulatory and economic risks;
the impact of our global operations, including our cost structure and global
manufacturing footprint, operations within Ukraine, and foreign currency and
exchange risk;
our product quality and safety and impact of product safety recalls and alleged
defects in products;
our ability to attract and retain highly skilled employees and wage inflation;
a tightening labor market, labor shortages or work stoppages impacting us, our
customers or our suppliers, such as recent labor strikes among certain OEMs and
suppliers;
our achievement of product cost reductions to offset customer-imposed price
reductions or other pricing pressures;
our ability to execute efforts to optimize our global supply chain and
manufacturing footprint, including opening new facilities and transferring
production;
our ability to source, consummate, integrate and achieve planned benefits of
strategic acquisitions, investments and, as applicable, exits;
any security breaches and other disruptions to our information technology
networks and systems, as well as privacy, data security and data protection
risks, including risks associated with use of artificial intelligence
capabilities in our business operations;
any loss or insolvency of our key customers and OEMs, or key suppliers;
our ability to project future sales volume based on third-party information,
based on which we manage our business;
the protection of our intellectual property in certain jurisdictions;
our compliance with global anti-corruption laws and regulations;
legal and regulatory proceedings and claims involving us or one of our major
customers;
the extensive regulation of our patient temperature management business;
risks associated with our manufacturing processes;
the effects of climate change and regulatory and stakeholder-imposed
requirements to address climate change and other sustainability issues;
our product quality and safety;
our borrowing availability under our revolving credit facility, as well as the
ability to access the capital markets, to support our planned growth; and
our indebtedness and compliance with our debt covenants.
Furthermore, important factors related to the combination with Modine
Performance Technologies (the “Transaction”) could cause actual results to
differ materially from those currently anticipated, including:
uncertainty of the expected financial performance of the combined company
following completion of the Transaction;
failure to realize the anticipated benefits of the Transaction;
the ability of the combined company to implement its business strategy;
difficulties and delays in the combined company achieving revenue and cost
synergies;
inability of the combined company to retain and hire key personnel;
evolving legal, regulatory and tax regimes;
changes in general economic and/or industry specific conditions or any
volatility resulting from the imposition of and changing policies, including
those policies with respect to tariffs; and
actions by third parties, including government agencies.
The foregoing risks should be read in conjunction with the Company's reports
filed with or furnished to the Securities and Exchange Commission (the “SEC”),
including “Risk Factors,” in its most recent Annual Report on Form 10-K and
subsequent SEC filings, for a discussion of these and other risks and
uncertainties. In addition, with reasonable frequency, we have entered into
business combinations, acquisitions, divestitures, strategic investments and
other significant transactions. Such forward-looking statements do not include
the potential impact of any such transactions that may be completed after the
date hereof, each of which may present material risks to the Company’s future
business and financial results. Moreover, we operate in a very competitive and
rapidly changing environment and new risks emerge from time to time.
Except as required by law, the Company expressly disclaims any obligation or
undertaking to update any forward-looking statements to reflect any change in
its strategies or expectations with regard thereto or any change in events,
conditions or circumstances on which any such statement is based.
Use of Non-GAAP Financial Measures
In addition to the results reported in accordance with GAAP throughout this
release, the Company has provided here or elsewhere information regarding:
adjusted earnings before interest, taxes, depreciation and amortization
(“Adjusted EBITDA”); Adjusted EBITDA margin; Adjusted net income; Adjusted
earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); Quarter-
to-date Operating Cash Flow; Free Cash Flow; Adjusted Free Cash Flow; Adjusted
Free Cash Flow Conversion rate; net capital expenditures (“net CAPEX”); Net
Debt; Liquidity; Net Leverage Ratio (“Net Leverage”); revenue, segment revenue
and product revenue excluding foreign currency translation and other specified
gains and losses; Adjusted operating expenses; Pro Forma Revenue; Pro Forma
Adjusted EBITDA; and Pro Forma Adjusted EBITDA Margin, each a non-GAAP financial
measure. The Company defines Adjusted EBITDA as earnings before interest, taxes,
depreciation and amortization, deferred financing cost amortization, non-cash
stock based compensation expenses, restructuring expenses, net, unrealized
currency gain or loss and other gains and losses not reflective of the Company’s
ongoing operations and related tax effects. The Company defines Adjusted EBITDA
margin as Adjusted EBITDA divided by product revenues. The Company defines
Adjusted net income as earnings adjusted by restructuring expenses, net,
unrealized currency gain or loss and other gains and losses not reflective of
the Company’s ongoing operations and related tax effects. The Company defines
Adjusted EPS as Adjusted net income divided by the Company’s weighted average
shares outstanding. The Company defines Quarter-to-date Operating Cash Flow as
Net cash provided by/(used in) operating activities for the current period, less
that of the immediately preceding period. The Company defines Free Cash Flow as
Net cash provided by/(used in) operating activities plus Proceeds from the sale
of property and equipment less Purchases of property and equipment. The Company
defines net CAPEX as Purchases of property and equipment less Proceeds from the
sale of property and
equipment. The Company defines Adjusted Free Cash Flow as Net cash provided
by/(used in) operating activities, excluding cash restructuring expenses, net
and other gains and losses not reflective of the Company’s ongoing operations,
less net CAPEX. The Company defines Adjusted Free Cash Flow Conversion rate as
Adjusted Free Cash Flow divided by Adjusted EBITDA. The Company defines Net Debt
as the principal amount of all Consolidated Funded Indebtedness (as defined in
the Credit Agreement) less cash and cash equivalents. The Company defines
Liquidity as the sum of cash and cash equivalents and availability under the
Company’s revolving line of credit. The Company defines Net Leverage as Net Debt
divided by Adjusted EBITDA for the trailing four fiscal quarters. The Company
defines revenue, segment revenue or product revenue excluding foreign currency
translation and other specified gains and losses as such revenue, excluding the
estimated effects of foreign currency exchange on revenue by translating actual
revenue using the prior period foreign currency exchange rates and excluding the
other items specified. The Company defines Adjusted operating expenses as
operating expenses excluding related non-cash stock based compensation,
restructuring expenses, net, and other gains and losses not reflective of the
Company’s ongoing operations. The Company defines Pro Forma Revenue as
Gentherm’s product revenues for the trailing four fiscal quarters (from the date
specified), plus Modine Performance Technologies’ Net sales for the trailing
four fiscal quarters (from the date specified), as reported by Modine
Manufacturing Company, adjusted to reflect the latest business structure. The
Company defines Pro Forma Adjusted EBITDA as Gentherm’s Adjusted EBITDA for the
trailing four fiscal quarters (from the date specified), plus Modine Performance
Technologies’ Adjusted EBITDA for the trailing four fiscal quarters (from the
date specified), as reported by Modine Manufacturing Company, adjusted to
reflect the latest business structure and go-forward operational alignment. The
Company defines Pro Forma Adjusted EBITDA Margin as Pro Forma Adjusted EBITDA
divided by Pro Forma Revenue.
The Company’s reconciliations are included in this release or can be found in
the supplemental materials for this reporting period on the Company’s website.
In evaluating its business, the Company considers and uses Quarter-to-date
Operating Cash Flow, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash
Flow Conversion rate, Net Debt, Net Leverage and Liquidity as supplemental
measures of its liquidity and the other non-GAAP financial measures as
supplemental measures of its operating performance. Management provides such
non-GAAP financial measures so that investors will have the same financial
information that management uses with the belief that it will assist investors
in properly assessing the Company's performance on a period-over-period basis by
excluding matters not indicative of the Company’s ongoing operating or liquidity
results and therefore enhance the comparability of the Company's results and
provide additional information for analyzing trends in the business. In
evaluating our non-GAAP financial measures, you should be aware that in the
future we may incur revenues, expenses, and cash and non-cash obligations that
are the same as or similar to some of the adjustments in our presentation of
non-GAAP financial measures. Our presentation of non-GAAP financial measures
should not be construed as an inference that our future results will be
unaffected by unusual or non-recurring items. There also can be no assurance
that we will not modify the presentation of our non-GAAP financial measures in
the future, and any such modification may be material. Other companies in our
industry may define and calculate these non-GAAP financial measures differently
than we do and those calculations may not be comparable to our metrics. These
non-GAAP measures have limitations as analytical tools, and when assessing the
Company's operating performance or liquidity, investors should not consider
these non-GAAP measures in isolation, or as a substitute for net income/(loss),
revenue or other consolidated income/(loss) statement or cash flow statement
data prepared in accordance with GAAP.
Non-GAAP measures referenced in this release and other public communications may
include estimates of future Adjusted EBITDA, Adjusted EBITDA margin, Adjusted
Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Adjusted EPS, Pro Forma
Revenue, Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin. The
Company has not reconciled the non-GAAP forward-looking guidance included in
this release to the most directly comparable GAAP measures because this cannot
be done without unreasonable effort due to the variability and low visibility
with respect to taxes and non-recurring items, which are potential adjustments
to future earnings. We expect the variability of these items to have a
potentially unpredictable, and a potentially significant, impact on our future
GAAP financial results.
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF (LOSS) INCOME
(Dollars in thousands, except per share data) (Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Pro… $ 405,… $ 386,… $ 1,21… $ 1,11…
rev…
Cost
of 310,… 291,… 927,… 844,…
sal…
Gro… 94,3… 95,1… 287,… 271,…
mar…
Ope…
exp…
Net
res…
and 23,4… 24,4… 71,4… 71,2…
dev…
exp…
Sel…
gen…
and 51,6… 42,8… 162,… 122,…
adm…
exp…
Res…
exp… 4,838 3,986 17,4… 10,6…
net
Loss
on
sale
of — — — 2,196
land
and
bui…
net
Tot…
ope… 79,9… 71,2… 251,… 206,…
exp…
Ope… 14,3… 23,8… 36,3… 64,9…
inc…
Int…
exp… (3,8… ) (3,3… ) (9,7… ) (10,… )
net
For…
cur… 193 339 (1,1… ) (27,… )
gain
(lo…
Oth…
inc… 116 — 300 (1,1… )
(lo…
Ear…
bef… 10,8… 20,8… 25,7… 25,5…
inc…
tax
Inc…
tax 13,4… 5,935 19,7… 10,2…
exp…
Net
(lo… $ (2,5… ) $ 14,9… $ 6,048 $ 15,2…
inc…
Bas…
(lo…
ear… $ (0.08 ) $ 0.49 $ 0.20 $ 0.50
per
sha…
Dil…
(lo…
ear… $ (0.08 ) $ 0.49 $ 0.19 $ 0.50
per
sha…
Wei…
ave…
num…
of 30,6… 30,4… 30,6… 30,6…
sha…
–
bas…
Wei…
ave…
num…
of 30,6… 30,7… 31,0… 30,8…
sha…
–
dil…
GENTHERM INCORPORATED REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN
CURRENCY TRANSLATION IMPACT (Dollars in thousands) (Unaudited)
Th… Ni…
Mo… Mo…
En… En…
Se… % Se… %
2… 30, 2… C… 2… 30, 2… C…
──────────────────────────────────────────────────────────────────────────────
C…
C… $ 21… $ 20… 7.1 % $ 63… $ 59… 8.0 %
S…
L…
a…
M… 70… 55… 27… % 20… 15… 33… %
C…
S…
C…
C… 51… 52… (1… )% 15… 14… 5.2 %
I…
C…
a… 7,… 8,… (7… )% 25… 22… 16… %
C…
E…
A…
C…
a… 34… 31… 8.8 % 1,… 91… 12… %
C…
S…
V… 21… 24… (1… )% 73… 72… 0.6 %
S…
O… 22… 31… (2… )% 77… 91… (1… )%
A…
S…
A… 39… 37… 4.4 % 1,… 1,… 9.0 %
s…
M… 14… 12… 14… % 37… 35… 4.2 %
s…
T… $ 40… $ 38… 4.7 % $ 1,… $ 1,… 8.9 %
C…
F…
c…
t… 1,… — 20… —
i…
(…
T…
C…
e…
f… $ 40… $ 38… 4.4 % $ 1,… $ 1,… 7.0 %
c…
t…
i…
(…
F…
c…
t…
i…
f…
t…
A…
s…
a…
M…
s…
w…
$…
a…
$…
r…
f…
t…
t…
m…
e…
S…
3…
2…
F…
c…
t…
i…
f…
A…
C…
a…
C…
S…
w…
$…
f…
t…
t…
m…
e…
S…
3…
2…
F…
c…
t…
i…
f…
t…
A…
s…
a…
M…
s…
w…
$…
a…
$…
r…
f…
t…
n…
m…
e…
S…
3…
2…
F…
c…
t…
i…
f…
A…
C…
a…
C…
S…
w…
$…
f…
t…
n…
m…
e…
S…
3…
2…
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED EBITDA AND
ADJUSTED EBITDA MARGIN (Dollars in thousands) (Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Net
(lo… $ (2,5… ) $ 14,9… $ 6,048 $ 15,…
inc…
Add
bac…
Dep…
and 14,7… 13,2… 43,0… 39,…
amo…
Inc…
tax 13,4… 5,935 19,7… 10,…
exp…
Int…
exp… 3,832 3,313 9,755 10,…
net
Adj…
Non…
sto… 2,925 3,980 10,3… 10,…
bas…
com…
Res…
exp… 4,838 3,986 17,4… 10,…
net
Unr…
cur… 681 1,865 855 30,…
loss
Mer…
and 6,528 — 34,1… —
acq…
exp…
Lea…
tra… 328 777 1,738 2,9…
exp…
Loss
on
sale
of — — — 2,1…
land
and
bui…
net
Oth… 328 928 (130 ) 2,0…
(a)
Adj… $ 45,0… $ 49,0… $ 143,… $ 134…
EBI…
Pro… $ 405,… $ 386,… $ 1,21… $ 1,1…
rev…
Net
(lo… (0.6 )% 3.9 % 0.5 % 1.4 %
inc…
mar…
Adj…
EBI… 11.1 % 12.7 % 11.8 % 12.0 %
mar…
(a)
Inc…
a
$1,…
dec…
in
fair
val…
of
an
equ…
inv…
for
the
nine
mon…
end…
Sep…
30,
202…
GENTHERM INCORPORATED RECONCILIATION OF NET (LOSS) INCOME TO ADJUSTED NET INCOME
AND ADJUSTED EARNINGS PER SHARE (Dollars in thousands, except per share data)
(Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Net
(lo… $ (2,5… ) $ 14,9… $ 6,048 $ 15,2…
inc…
Amo…
of
acq… 2,427 1,676 5,802 4,873
rel…
int…
Res…
exp… 4,838 3,986 17,4… 10,6…
net
Unr…
cur… 681 1,865 855 30,3…
loss
Mer…
and 6,528 — 34,1… —
acq…
exp…
Lea…
tra… 328 777 1,738 2,935
exp…
Loss
on
sale
of — — — 2,196
land
and
bui…
net
Oth… (116 ) 928 (574 ) 2,055
Tax
eff… (2,0… ) (1,5… ) (6,5… ) (13,… )
of
abo…
Adj…
net $ 10,0… $ 22,5… $ 58,9… $ 54,8…
inc…
Wei…
ave…
sha…
out…
Bas… 30,6… 30,4… 30,6… 30,6…
Dil… 30,6… 30,7… 31,0… 30,8…
(Lo…
Ear…
per
sha…
as
rep…
Bas… $ (0.08 ) $ 0.49 $ 0.20 $ 0.50
Dil… $ (0.08 ) $ 0.49 $ 0.19 $ 0.50
Adj…
ear…
per
sha…
Bas… $ 0.33 $ 0.74 $ 1.93 $ 1.79
Dil… $ 0.33 $ 0.73 $ 1.90 $ 1.78
GENTHERM INCORPORATED CONSOLIDATED CONDENSED BALANCE SHEETS (Dollars in
thousands, except share data) (Unaudited)
September 30, 2026 December 31, 2025
──────────────────────────────────────────────────────────────────────────────
ASSETS
Current Assets:
Cash and cash $ 252,098 $ 160,833
equivalents
Accounts receivable, 326,217 281,083
net
Inventory:
Raw materials 127,403 128,314
Work in process 44,437 35,429
Finished goods 91,647 88,959
Inventory, net 263,487 252,702
Other current assets 85,678 82,332
Total current assets 927,480 776,950
Property and 263,561 270,614
equipment, net
Goodwill 122,258 108,918
Other intangible 63,858 52,796
assets, net
Operating lease 48,674 56,524
right-of-use assets
Deferred income tax 93,853 93,552
assets
Other non-current 42,615 37,075
assets
Total assets $ 1,562,299 $ 1,396,429
LIABILITIES AND
SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable $ 298,183 $ 260,487
Current lease 7,846 9,646
liabilities
Current maturities of 912 73
long-term debt
Other current 144,999 134,104
liabilities
Total current 451,940 404,310
liabilities
Long-term debt, less 319,531 189,000
current maturities
Non-current lease 42,469 48,105
liabilities
Pension benefit 3,281 3,748
obligation
Other non-current 23,760 30,943
liabilities
Total liabilities $ 840,981 $ 676,106
Shareholders’ Equity:
Common Stock:
No par value;
110,000,000 shares
authorized 30,710,902
and 30,526,231
issued and 13,442 5,611
outstanding at
September 30,
2026 and December 31,
2025, respectively
Paid-in capital 1,590 1,590
Accumulated other (13,848 ) (964 )
comprehensive loss
Accumulated earnings 720,134 714,086
Total shareholders’ 721,318 720,323
equity
Total liabilities and
shareholders’ $ 1,562,299 $ 1,396,429
equity
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Dollars
in thousands) (Unaudited)
Nine Months Ended
Operating September 30,
Activities: 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net income $ 6,048 $ 15,298
Adjustments to
reconcile net
income to
net cash provided
by operating
activities:
Depreciation and 44,201 39,478
amortization
Deferred income (9,548 ) (12,836 )
taxes
Stock based 10,371 10,573
compensation
Loss on disposition
of property and 121 2,671
equipment
Provisions for 4,086 5,234
inventory
Other non-cash
items, including
unrealized foreign (1,018 ) 30,957
currency (gain)
loss
Changes in assets
and liabilities:
Accounts (43,474 ) (20,543 )
receivable, net
Inventory (22,133 ) (20,136 )
Other assets (1,403 ) (22,325 )
Accounts payable 43,305 33,514
Other liabilities 5,451 25,935
Net cash provided
by operating 36,007 87,820
activities
Investing
Activities:
Purchases of
property and (22,558 ) (33,378 )
equipment
Proceeds from the
sale of property 83 3,770
and
equipment
Acquisition of
business, net of (34,152 ) —
cash
acquired
Cost of technology (121 ) (915 )
investments
Proceeds from
deferred purchase
price of — 744
factored
receivables
Net cash used in
investing (56,748 ) (29,779 )
activities
Financing — —
Activities:
Borrowings on debt 204,000 72,000
Repayments of debt (85,887 ) (103,112 )
Cash paid for (2,761 ) —
financing new loans
Taxes withheld and
paid on employees' (2,540 ) (1,306 )
stock based
compensation
Cash paid for the
repurchase of — (10,015 )
Common
Stock
Net cash provided
by (used in) 112,812 (42,433 )
financing
activities
Foreign currency (806 ) 4,508
effect
Net increase in
cash and cash 91,265 20,116
equivalents
Cash and cash
equivalents at 160,833 134,134
beginning
of period
Cash and cash
equivalents at end $ 252,098 $ 154,250
of
period
GENTHERM INCORPORATED OTHER NON-GAAP RECONCILIATIONS (Dollars in thousands)
(Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Tot…
ope… $ 79,9… $ 71,2… $ 251,… $ 206,…
exp…
Res…
exp… (4,8… ) (3,9… ) (17,… ) (10,… )
net
Non…
sto… (2,8… ) (3,9… ) (9,8… ) (10,… )
bas…
com…
Mer…
and (6,5… ) — (34,… ) —
acq…
exp…
Lea…
tra… (328 ) (777 ) (1,7… ) (2,9… )
exp…
Loss
on
sale
of — — — (2,1… )
land
and
bui…
net
Oth… — (927 ) — (927 )
Adj…
ope… $ 65,3… $ 61,6… $ 188,… $ 179,…
exp…
September 30, 2026 September 30, 2025
──────────────────────────────────────────────────────────────────────────────
Cash and cash equivalents $ 252,098 $ 154,250
Revolving line of credit 242,141 307,938
availability
Total liquidity $ 494,239 $ 462,188
September 30, 2026 September 30, 2025
──────────────────────────────────────────────────────────────────────────────
Current maturities of $ 912 $ 109
long-term debt
Long-term debt, less 319,531 189,000
current maturities
Total Debt 320,443 189,109
Cash and cash equivalents 252,098 154,250
Net Debt $ 68,345 $ 34,859
Adjusted EBITDA for the
trailing four $ 181,034 $ 175,620
fiscal quarters
Net Leverage 0.4 0.2
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Net
cash
pro… $ 33,7… $ 56,1… $ 36,0… $ 87,8…
by
ope…
act…
Pur…
of
pro… (8,3… ) (9,6… ) (22,… ) (33,… )
and
equ…
Pro…
from
the
sale 13 25 83 3,770
of
pro…
and
equ…
Free
Cash 25,3… 46,4… 13,5… 58,2…
Flow
Cash
eff…
of
adj…
Res…
exp… 5,352 2,308 11,9… 6,648
net
Mer…
and 11,9… 15 32,9… 15
acq…
exp…
Lea…
tra… 989 650 1,015 6,711
exp…
Oth… — 2,103 — 704
Adj…
Free $ 43,6… $ 51,5… $ 59,4… $ 72,2…
Cash
Flow